🔎 Trials Near Me

Akèy › Limfom zòn marenal › Washington › Seattle

Etid klinik pou Limfom zòn marenal nan Seattle, WA

9 etid pou Limfom zòn marenal ap chèche patisipan nan sit nan ak bò kote Seattle (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Ap rekriteFaz 1/2
  • Fred Hutchinson Cancer Research Center, Seattle
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT05006716

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Ap rekriteFaz 1
  • Swedish Cancer Institute (SCI), Seattle
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07101328

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

Ap rekriteFaz 1
  • Fred Hutchinson Cancer Center, Seattle
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT07121946

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

Ap rekriteFaz 2Volontè an sante akeyi
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
6 Months · Tout sèks · Mizajou May 29, 2026 · NCT04195633

Study of SGR-1505 in Mature B-Cell Neoplasms

Ap rekriteFaz 1
  • Fred Hutchinson Cancer Center, Seattle
Laj 18 ak plis · Tout sèks · Mizajou Feb 13, 2026 · NCT05544019

A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma

Ap rekriteFaz 1/2
  • University of Washington-Seattle Cancer Care Alliance, Seattle
Laj 18 ak plis · Tout sèks · Mizajou Jan 30, 2026 · NCT04669171

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Seattle
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

Ap rekriteFaz 1
  • Swedish Cancer Institute, Seattle
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2025 · NCT05780034

Etid Limfom zòn marenal nan lòt vil

Lòt etid nan Seattle

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.